MEGHAN DORAN: Open Payments
NPI 1871848481 · FAYETTEVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$656 in 36 payments from 8 companies in 2025. Trend: 2023 $960 · 2024 $571 · 2025 $656
Food & beverage: $656
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $190 |
| ABBVIE INC. | 6 | $122 |
| Lilly USA, LLC | 5 | $105 |
| Novartis Pharmaceuticals Corporation | 5 | $99 |
| UCB, Inc. | 2 | $56 |
| LEO Pharma Inc. | 2 | $39 |
| Galderma Laboratories, L.P. | 1 | $30 |
| Regeneron Healthcare Solutions, Inc. | 1 | $14 |
Products named: TREMFYA, TALTZ, SKYRIZI, COSENTYX, Bimzelx, NEMLUVIO, ANZUPGO, Rhapsido.
Industry payments across NY — which companies pay providers there.
